Lucentis price cut ends PCT-Novartis dispute
July 26, 2012Sales and Marketing ABPI, NHS, PCTs, Roche, SHIP Cluster, avastin
An NHS body has been persuaded to reverse its policy of recommending Avastin for wet AMD. The Southampton, Hampshire, Isle …
NHS Commissioning Board appoints key directors
July 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Sutton, Lyn Simpson, NHS Commissioning, PCT
The NHS Commissioning Board Authority has announced the appointment of the two director posts in the national leadership team of …
GSK falters in Q2 as austerity measures bite
July 25, 2012Sales and Marketing Benylsta, GSK, Q2, Seretide, Witty
GlaxoSmithKline posted a loss in its second quarter results, as pressure in mature markets continues to affect the firm. Pharmaceutical …
Europe looking to revamp clinical trial laws
July 25, 2012Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials
The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …
FDA approves Forest’s COPD drug
July 25, 2012Sales and Marketing COPD, FDA, Forest, Tudorza Pressair
US regulators have approved Forest Laboratories’ new chronic obstructive pulmonary disease (COPD) drug. Tudorza Pressair (aclidinium bromide) has been given …
Parexel’s BioPharm Unit to aid smaller R&D firms
July 25, 2012Research and Development Parexel, R&D, biotech
Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …
ADMA Biologics appoints Lawrence Guiheen to board of directors
July 25, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ADMA Biologics, Lawrence Guiheen
Late-stage biotech firm ADMA Biologics has announced it has appointed Lawrence Guiheen to its board of directors. Guiheen said: “Having …
Physios and podiatrists to gain new prescribing powers
July 25, 2012Sales and Marketing Department of Health, GPs, Physios, government, prescribing
Physiotherapists and podiatrists are set to gain new prescribing powers by 2014. Ministers are looking to amend medicines legislation so …
NICE yes for Xarelto to treat blood clots
July 25, 2012Sales and Marketing Bayer, DVT, NHS, NICE, Pradaxa, VTE, Xarelto
NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in …
Comms agency WCG expands team
July 24, 2012Medical Communications London, WCG, healthcare comms
WCG has announced a string of appointments whilst also being ranked twelfth among healthcare firms in PRWeek’s UK league tables. …
Speedy approval for Onyx’ multiple myeloma drug
July 24, 2012Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade
Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma. Kyprolis (carfilzomib), a …
Pfizer and Janssen’s Alzheimer’s drug fails
July 24, 2012Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab
Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …
NICE to assess high cost drugs for rare conditions
July 24, 2012Sales and Marketing AGNSS, NHS, NICE, Rawlins, rare conditions
NICE is to be responsible next year for assessing high cost drugs for people with rare medical conditions as part …
Microneedles could transform delivery of drugs to the eye
July 24, 2012Manufacturing and Production, Research and Development AMD, avastin, microneedles
Researchers in the US have demonstrated for the first time that drugs can be successfully delivered to the eye using …
ABPI names new Medical, Innovation and Research director
July 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bina Rawal, Stephen Whitehead
The ABPI has named its new Medical, Innovation and Research director as Dr Bina Rawal, who will join the trade …
EMA recommends first new gene therapy
July 24, 2012Business Services, Research and Development, Sales and Marketing CHMP, EMA, Glybera, uniQure
Glybera is now on the cusp of becoming the first gene therapy treatment to be approved in the West. The …
Pharma buoys Albemarle results in second quarter
July 24, 2012Manufacturing and Production Albemarle, manufacturing
Albemarle succumbed to pressure in the market in the second quarter as sales fell 8% to $685 million, although the …
Supplier defect blamed in Hospira recall case
July 24, 2012Manufacturing and Production FDA, Hospira, Michael Ball
Hospira has concluded that a supplier defect was the root cause of its recall of four cancer drugs in the …
Contract research news in brief
July 23, 2012Research and Development Clinipace Worldwide, Medpace, Paraxel, Synexus, eResearch Technologies and invivodata
A round-up of recent developments in the contract research sector, including updates from Parexel, Medpace, Clinipace, Synexus and ERT.
BBSRC appoints new director of science
July 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BBSRC, Melanie Welham
BBSRC the government-funded bioscience research organisation has announced the appointment of Professor Melanie Welham as director of science. Welham is …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
